CDER’s current proposal to withdraw the accelerated acceptance of Makena (HPC) was based on a sizable randomized trial that failed to verify the advantage of this drug to newborns or lessen the potential risk of https://blakeaqho461072.wikifiltraciones.com/3115204/mkena_com_options